SUMMARY Two cases of intracranial dissemination of primary intramedullary spinal cord gliomas are reported, with a review of the literature. One patient had a post mortem confirmation and in the second, cerebral CT scan and CSF examination demonstrated the occurrence of intracranial dissemination. CSF protein was elevated on both patients and malignant cells were found late in only the one patient. Both patients had raised intracranial pressure. The mechanisms of dissemination and of raised intracranial pressure are discussed. Such dissemination may be more common than previously realised.
Dissemination of spinal cord gliomas into the cranial cavity has been reported infrequently while spread from intracranial glial tumours to the spinal subarachnoid space is not uncommon. We report two cases in young women which were seen within one year of each other and speculate on the mechanism of the extensive ventricular seeding that occurred.
Case reports Case I
In December 1981, a 38-year-old woman presented with a six weeks history of right leg weakness and left leg paraesthesiae. There was no sphincter disturbance. Examination revealed mild weakness of right hip flexors, brisk knee jerks, flexor plantar responses and impaired appreciation of pinprick below T1 1 on the left. Neurological examination was otherwise normal. A myelogram to T3 was normal. CSF revealed no malignant cells but many lymphocytes and macrophages and total protein was raised to 0-65 g/l. IgG/Albumin ratio was normal. A diagnosis of possible transverse myelitis was made.
In late January 1982 the patient re-presented with sudden onset of severe headache, vomiting and neck stiffness. Neurological examination was unchanged apart from increased weakness of right leg. Examination of CSF revealed no white blood cells, 222 red blood cells with no xanthochromia, protein of 18-8 g/l and glucose of 2-2 mmol/l. The headache was rapidly relieved by lumbar puncture. Headache and vomiting soon recurred and florid bilateral papilloedema developed. Lower Microscopically the thoracic cord tumour was a malignant astrocytoma showing marked cellularity, nuclear pleomorphism and hyperchromatism, vascular endothelial proliferation and areas of necrosis. Numerous bizarre giant cells with swollen eosinophilic cytoplasm and intracytoplasmic inclusion were probably the result of irradiation (fig 3a) . Radiation may also have contributed to the oedema, necrosis and vascular reaction. Maximal tumour involvement was found in the third thoracic cord segment where there was replacement of the normal structures of the right side of the cord and extension across the midline anteriorly. Intramedullary tumour infiltrate extended distally to the seventh thoracic segment. There was leptomeningeal invasion with dense subarachnoid infiltrate encasing spinal nerve roots and blood vessels at all levels and invading the nerve roots of the cauda equina. Ascending spread in the intracranial subarachnoid space involved cranial nerve roots and there was direct invasion of the pineal gland from tumour in the quadrigeminal cistern. Multiple microscopic ependymal tumour deposits were present throughout the ventricular system with scattered superficial foci of subependymal infiltration. There was more extensive subependymal infiltration surrounding the infundibular recess of the third ventricle to form the tumour nodule which had been observed macroscopically (figs 3b, 3c, 3d). The histological features of the intracranial deposits were those of malignant astrocytoma, consistent with spread from the intramedullary spinal cord tumour. The tumour deposits were highly cellular with pleomorphic hyperchromatic nuclei, moderate mitotic activity, associated capillary endothelial proliferation and small foci of necrosis. The appearances were similar to those in the spinal cord tumour but there was an absence of the bizarre giant cells attributed to irradiation in the primary lesion. The In September 1982 she re-presented with increased pain, numbness and weakness in the left leg. A repeat myelogram showed marked enlargement of the conus from Ti 1 to T12. CSF protein was 0-86 gil, glucose 2-9 mmol/l and microscopy and cytology were normal. A further 6500 rads were given to the lower cord over seven weeks. Again there was improvement in strength.
In January 1983 she presented with a ten day history of diffuse headache and drowsiness. There was early papilloedema but no other change. CT scan of brain revealed multiple periventricular lesions which showed a marked contrast enhancement (fig 5) . Examination of CSF revealed malignant cells consistent with astrocytoma, protein was 10 g/l and glucose was 3 4 mmol/l. The patient was treated with dexamethasone and metoclopramide but returned one month later with headache, vomiting and drowsiness. On There were also regions of contrast enhancement in the left fronto-parietal region and left basal ganglia (fig 7) . The patient died in May 1983 in her home town and necropsy was not performed.
Discussion
Gliomas account for 8% of primary spinal cord tumours.' Their spread from spinal cord to the cranial cavity has seldom been documented while spread of intracranial gliomas to the spinal canal has been repeatedly noted.2-5 A review of the literature reveals that 14 necropsy-proven cases of spinal cord tumours with intracranial dissemination have been reported: see table. The patients were generally young with an age range from 5 to 48 years and duration of illness was less than one year in most cases.
The time course for the progression of symptoms in our patients makes it unlikely that the primary lesion was intracranial, or that the lesions were multifocal in origin. In Case 1 the initial symptoms in the lower limbs preceded the symptoms of increased intracranial pressure by three months. Cerebral CT scans from the onset of intracranial symptoms failed to reveal any evidence of a primary intracranial lesion. Necropsy demonstrated a picture consistent with invasion by tumour deposits from the ventricular system but no evidence of a primary intracranial neoplasm. Case 2 had symptoms related to a biopsy-proven intramedullary conus tumour for 24 months prior to the development of any cerebral symptoms. A cerebral CT scan was performed with the advent of cerebral symptoms and showed multiple periventricular deposits but no evidence of a primary intracerebral lesion. Serial CT scans then showed evidence of intracerebral invasion. Although necropsy was not performed in Case 2, it is most improbable that a primary cerebral lesion was present that could seed to the conus and yet remain otherwise clinically silent for 24 months, particularly given the pattern of ventricular to cerebral spread of the deposits seen on serial cerebral CT scans.
Meningeal invasion paves the way for spread in the CSF pathways. Other factors may then determine the extent and rate of dissemination and the site of metastatic deposits. All four of Eade and Urich' s metastasising spinal cord gliomas were histologically malignant.'4 Kopelson and Linggood have also stressed the prognostic importance of the histological grade of intramedullary spinal cord gliomas.'8 This appears to apply to our two cases. Case 1, with malignant astrocytoma, survived only nine months from the onset of her illness, whereas Case 2, with the lower grade tumour survived for 28 months. In Case 2, however, in the absence of necropsy examination we cannot exclude sampling error in the biopsy or subsequent anaplastic change in the tumour.
Another possible histological determinant of tumour behaviour is oligodendroglial differentiation.'9 Oligodendrogliomas are noted for their propensity for spread. Eade and Urich described oligodendroglial differentiation in three of their four cases of disseminated spinal cord gliomas. No evidence of such differentiation was found in our two cases but, again, the small biopsy in Case 2 may not have been representative of the tumour and its numerous deposits. We note that in two of the three cases with oligodendroglial differentiation in Eade and Urich' s report the initial biopsies contained only astrocytoma.
The remote sites of tumour deposition in the subarachnoid space and the ventricular system are probably related to CSF flow.20 The marked tumour seeding within the ventricular system in both cases may be due to tumour seeding first to the basal cisterns and cisterna magna with formation of a communicating hydrocephalus. Such flow of CSF into The place for cranio-spinal irradiation in patients with spinal cord tumours who have malignant cells in CSF or abnormalities on cerebral scanning is uncertain. The efficacy of adjuvant chemotherapy is even less certain and should be used in centres where a trial can be conducted. It should be given via an Omaya reservoir to achieve worthwhile intraventricular drug levels.
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